Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WHWK
2576
Whitehawk Therapeutics
WHWK
$251M
| $641K | ﹤0.01% |
439,222
-104,500
| -19% | -$194K |
|
|
KW
2577
DELISTED
Kennedy-Wilson Holdings
KW
| $640K | ﹤0.01% |
65,800
-223,100
| -77% | -$2.09M |
|
|
ACR
2578
ACRES Commercial Realty
ACR
$101M
| $639K | ﹤0.01% |
50,094
-32,178
| -39% | -$427K |
|
|
NFGC
2579
New Found Gold
NFGC
$645M
| $637K | ﹤0.01% |
+225,119
| New | +$793K |
|
2580
Greenwich LifeSciences
GLSI
$250M
| $637K | ﹤0.01% |
36,900
-600
| -2% | -$8.77K |
|
2581
Dimensional US Small Cap ETF
DFAS
$16B
| $637K | ﹤0.01% |
+10,600
| New | +$638K |
|
2582
iShares Russell Top 200 Value ETF
IWX
$4.04B
| $636K | ﹤0.01% |
8,500
-10,700
| -56% | -$800K |
|
2583
Entrada Therapeutics
TRDA
$285M
| $636K | ﹤0.01% |
+44,600
| New | +$634K |
|
|
HITI
2584
High Tide
HITI
$206M
| $634K | ﹤0.01% |
287,100
-110,900
| -28% | -$259K |
|
2585
Champions Oncology
CSBR
$69.7M
| $634K | ﹤0.01% |
122,591
-2,100
| -2% | -$10.2K |
|
|
ICAD
2586
DELISTED
iCAD Inc
ICAD
| $632K | ﹤0.01% |
486,190
-4,922
| -1% | -$7.58K |
|
2587
Dimensional US Core Equity 2 ETF
DFAC
$49.9B
| $632K | ﹤0.01% |
+19,600
| New | +$618K |
|
2588
Insteel Industries
IIIN
$633M
| $632K | ﹤0.01% |
20,400
+200
| +1% | +$6.56K |
|
|
MNTX
2589
DELISTED
Manitex International, Inc.
MNTX
| $629K | ﹤0.01% |
142,073
+16,433
| +13% | +$95.2K |
|
2590
Vanguard Financials ETF
VFH
$14B
| $629K | ﹤0.01% |
6,300
-5,100
| -45% | -$509K |
|
2591
Betterware México
BWMX
$609M
| $628K | ﹤0.01% |
43,000
| – | – |
|
2592
Tompkins Financial
TMP
$1.45B
| $627K | ﹤0.01% |
12,830
-900
| -7% | -$41.5K |
|
|
AD
2593
Array Digital Infrastructure
AD
$3.11B
| $625K | ﹤0.01% |
11,200
-27,900
| -71% | -$1.23M |
|
2594
iShares US Equity Factor ETF
LRGF
$3.73B
| $624K | ﹤0.01% |
11,200
-9,400
| -46% | -$505K |
|
|
RAPT
2595
DELISTED
RAPT Therapeutics
RAPT
| $622K | ﹤0.01% |
25,488
+13,238
| +108% | +$611K |
|
|
PMD
2596
DELISTED
Psychemedics Corporation
PMD
| $622K | ﹤0.01% |
256,963
-2,900
| -1% | -$7.37K |
|
2597
Citizens
CIA
$200M
| $617K | ﹤0.01% |
226,794
-5,000
| -2% | -$12.6K |
|
2598
BioLife Solutions
BLFS
$1.72B
| $615K | ﹤0.01% |
+28,700
| New | +$557K |
|
2599
Perspective Therapeutics
CATX
$364M
| $615K | ﹤0.01% |
61,660
+58,485
| +1,842% | +$846K |
|
|
EHAB
2600
DELISTED
Enhabit
EHAB
| $615K | ﹤0.01% |
68,900
+58,500
| +563% | +$559K |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.